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Background: Different histone post-translational modifications (PTMs) fine-tune and integrate different cellular
signaling pathways at the chromatin level. ADP-ribose modification of histones by cellular ADP-ribosyltransferases
such as ARTD1 (PARP1) is one of the many elements of the histone code. All 5 histone proteins were described to
be ADP-ribosylated in vitro and in vivo. However, the crosstalk between ADP-ribosylation and other modifications is
little understood.
Results: In experiments with isolated histones, it was found that ADP-ribosylation of H3 by ARTD1 prevents
H3 methylation by SET7/9. However, poly(ADP-ribosyl)ation (PARylation) of histone H3 surprisingly allowed
subsequent methylation of H1 by SET7/9. Histone H1 was thus identified as a new target for SET7/9. The SET7/9
methylation sites in H1.4 were pinpointed to the last lysine residues of the six KAK motifs in the C-terminal domain
(K121, K129, K159, K171,
K177 and K192). Interestingly, H1 and the known SET7/9 target protein H3 competed with each other for
SET7/9-dependent methylation.
Conclusions: The results presented here identify H1.4 as a novel SET7/9 target protein, and document an intricate
crosstalk between H3 and H1 methylation and PARylation, thus implying substrate competition as a regulatory
mechanism. Thereby, these results underline the role of ADP-ribosylation as an element of the histone code.
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Histones are nuclear proteins that package and order the
DNA into nucleosomes [1]. Five major families of his-
tones exist: H1 (H5), H2A, H2B, H3, and H4. Two cop-
ies of the core histones H2A, H2B, H3 and H4 form the
octameric nucleosome core particles [2]. Unlike the
other histones, only one copy of the linker histone H1 is
present and stabilizes the DNA, which is wrapped
around the core nucleosome [3]. Linker histones bind to
both the nucleosome and the linker DNA region (ap-
proximately 20 to 80 nucleotides in length) between
nucleosomes. The interaction of H1 with the nucleo-
some and additional DNA stretches at the entry/exit of
the nucleosome forms the chromatosome and leads to* Correspondence: hottiger@vetbio.uzh.ch
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reproduction in any medium, provided the orhigher order chromatin structure [4]. Many experiments
addressing H1 function have been performed with puri-
fied, processed chromatin under low-salt conditions, but
the in vivo role of H1 is less clear. Cellular studies have
shown that overexpression of H1 can cause aberrant nu-
clear morphology and chromatin structure and, depend-
ing on the gene, H1 can serve as either a positive or a
negative regulator of transcription [5]. Similar to the
core histones, H1 is composed of three domains [6]. The
N-terminus is a short, flexible segment rich in basic
amino acids, the central domain exhibits a globular
structure composed of a winged helix motif [6] and
the C-terminus is predominantly composed of lysine,
alanine and proline residues and is the main determin-
ant for H1 binding to chromatin [7]. Among the five
histone families of the chromatosome, the linker his-
tone H1 is the least conserved. In the human genome,
11 genes encoding H1 variants have been identified andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kassner et al. Epigenetics & Chromatin 2013, 6:1 Page 2 of 9
http://www.epigeneticsandchromatin.com/content/6/1/1are transcribed either ubiquitously or in a cell type-
specific manner [4,8]. The study described here focuses
on histone H1.4, a histone variant that is expressed
in somatic cells during S phase. Together with H1.2
it is the predominant histone variant in most cell
types. Similar to the core histones, linker histones are
subject to extensive post-translational modifications
(PTMs), including phosphorylation, methylation and
acetylation [9].
SET7/9 (also SET7, SET9, SETD7 or KMT7) is a
mono-methyltransferase for the lysine residue at pos-
ition 4 of histone H3 (H3K4) [10,11] that was linked to
transcriptional activation. It methylates the consensus
motif [K>R][S>KYARTPN][Kme] and prefers lysine resi-
dues within positively charged regions [12]. However,
SET7/9 exhibits only weak lysine methyltransferase ac-
tivity towards H3 in nucleosomes in vitro, suggesting
that additional factors may affect SET7/9-dependent
H3K4 methylation in vivo, or that histone proteins are
not the main substrates of SET7/9. Lysine methylation
can be reversed by demethylases of the lysine-specific
demethylase (LSD) family or the Jumonji-C domain fam-
ily of proteins [13,14].
In contrast to the canonical PTMs of the histone code,
adenosine diphosphate (ADP)-ribosylation is much less
studied. ADP-ribosylation comprises the transfer of the
ADP-ribose moiety from the co-substrate nicotinamide ad-
enine dinucleotide (NAD+) onto specific amino acid side
chains of acceptor proteins or to pre-existing protein-linked
ADP-ribose units by ADP-ribosyltransferases (ARTs).
Mammalian ARTs can be divided into two groups accord-
ing to their similarity to the bacterial diphtheria and cholera
toxins - the ARTDs (also known as poly(ADP-ribose) poly-
merases (PARPs)) and ARTCs, respectively [15]. ARTD1
(PARP1) is the best-studied member of the ARTD family
and represents a highly abundant (on average 1 × 106
molecules per cell), chromatin-associated enzyme that is
responsible for most (about 90%) of the cellular PAR
generation [16,17]. It is implicated in many cellular
processes such as the genotoxic stress response, cell cycle
regulation, gene expression, differentiation and aging
[18,19]. The major modification target of ARTD1 is ARTD1
itself, but it also modifies other nuclear proteins including
all five histone proteins in vitro and in vivo [20]. In native
chromatin, histone H1 is the main ADP-ribose acceptor,
but depending on the chromatin composition and the
accessibility of different histones, the ADP-ribosylation
pattern of histones varies [21,22]. Mass spectrometry and
electron-transfer dissociation (ETD) identified for the first
time K13 of histone H2A, K30 of H2B, K27 and K37 of H3
as well as K16 of H4 as ADP-ribose acceptor sites
(catalyzed by ARTD1) [23].
Crosstalk between different PTMs occurs directly by
competition for acceptor sites or indirectly by changesin the accessibility of chromatin for modifying enzymes.
The observation that specific lysine residues serve as
ADP-ribose acceptors is important because the same
amino acid residues are potential acetylation and methy-
lation sites [24]. It is therefore likely that competition for
acceptor sites between different histone PTMs such as
ADP-ribosylation, acetylation, methylation and phos-
phorylation causes crosstalk [20]. This has been demon-
strated by the finding that acetylation of lysine residue
K16 of histone H4 inhibits ADP-ribosylation in vitro [23],
which suggests that different crosstalk likely exists
in vivo as well. Similarly, H1.4 K26 dimethylation and
AuroraB-mediated phosphorylation of S27 have been
reported to interfere with each other [25]. Whether
or not other modifications of the histone code such
as methylation or phosphorylation also crosstalk with
ADP-ribosylation has not been studied before.
Here, we define the linker histone H1.4 as a novel
target of SET7/9-dependent methylation, identify lysines
K121, K129, K159, K171, K177 and K192 as methyl
acceptor sites and describe crosstalk between H1.4
methylation and ADP-ribosylation as well as competi-
tion with histone H3 methylation.Results and discussion
PARylation inhibits SET7/9-dependent methylation of
histone H3
ADP-ribosylation is a PTM of a wide variety of target
proteins, including histones [20,23,26]. However, since
histone tails are subject to many types of PTMs, cross-
talk between different modifications likely exists.
Therefore, it was investigated whether histone PARylation
by ARTD1 affects consecutive SET7/9-dependent H3
methylation. A histone mix was PARylated for different
time periods and then subjected to methylation assays with
SET7/9 and radio-labelled S-adenosyl-L-(methyl-14C)
methionine (14C-SAM) as methyl donor. ARTD1 and
histones were both strongly PARylated and the level
of modification correlated with the reaction times
(see Additional file 1). In the absence of PARylation,
mainly core histones, which comprise H3, were methylated
(time-point 0) (Figure 1A). However, after 1 minute of
PARylation of the histones by ARTD1, the methylation of
core histones was already strongly reduced.
As a control for these results, recombinant H3 was
incubated with ARTD1, NAD+ and with or without
DNA (to stimulate ARTD1) and 3-AB (to inhibit
ARTD1). H3 was methylated by SET7/9 if ARTD1 was
inactive or inhibited (Figure 1B, lanes 1 and 4), but pre-
vented in the samples containing activated ARTD1
(Figure 1B, lanes 2 and 3). PARylation of SET7/9 was
not the cause for this effect, because the methyltransfer-
ase was only added after the PARylation reaction and
Figure 1 PARylation inhibits SET7/9-dependent methylation of histone H3 and H1. (A) ARTD1 was auto-modified for the indicated times
and then inhibited by addition of PJ-34. A histone mix was added to the reaction either before or after the inhibition of ARTD1. Methylation was
started after PJ-34 addition by adding SET7/9 and 14C-SAM. Proteins were separated by SDS-PAGE, stained with Coomassie blue (CB, lower blot)
and methylation was analyzed by autoradiography (14C, upper blot). The asterisk marks the shift of automodified ARTD1. (B) H3 was incubated
with ARTD1 and 160 μM NAD+. Activating DNA and PARP inhibitor 3-AB were present during the reaction as indicated. Methylation was then
started by addition of SET7/9 and 14C-SAM ± 3-AB was added directly before addition of SET7/9 after the PAR reaction. (C) Influence of ARTD1 on
H1 methylation as in (B). The approximate molecular weight is indicated on the left of each gel/blot.
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(Figure 1B, lanes 2 and 3).
PARylation of histone H3 allows methylation of H1 by
SET7/9
Interestingly, ADP-ribosylation of H3 for 1 or 2 minutes
and subsequent inhibition of its methylation resulted in
an unexpected and strong H1 methylation (Figure 1A).
In order to confirm H1 methylation by SET7/9, experi-
ments with purified H1 were performed. As before, H1
was incubated with ARTD1, NAD+ and with or without
DNA and 3-AB. Similar to H3, histone H1 was methy-
lated by SET7/9 in the absence of active ARTD1, but H1
methylation was completely inhibited by PARylation
(Figure 1C). These results suggested that in addition to
H3, histone H1 is a new methylation target of SET7/9
and that prior PARylation of H1 and H3 prevents con-
secutive methylation by SET7/9.
Histones H1 and H3 compete for SET7/9-dependent
methylation
The results presented so far suggested that H1 and H3
are both methylated by SET7/9, but only in the absence
of PARylation. ARTD1-dependent PARylation might
thus modulate which histone protein is methylated. To
test this hypothesis, in vitro competition experiments
with or without PARylation of H1 and H3 were per-
formed. H1 and H3 were strongly methylated by SET7/9
if present alone (Figure 2A, lanes 1 and 5). However, H1
and H3 competed with each other when present in thesame reaction and thus lead to a reduced methylation
signal (lanes 2 to 4). Prior PARylation of histone H3
completely abolished its competing activity for SET7/9-
dependent H1 methylation (lanes 6 to 7). To further
study and confirm this finding, a PARylation time course
experiment with histone H1 or histone mix prior to
SET7/9 methylation was performed. Set7/9-dependent
methylation of H1 was abolished after 15 minutes of
PARylation by ARTD1 (Figure 2B). In contrast, H3
methylation in a histone mix was already inhibited after
5 minutes of ARTD1 treatment, which lead to consecu-
tive H1 methylation by Set7/9 (Figure 2C). In both cases,
addition of the histones after the PARylation reaction
did not influence consecutive Set7/9-dependent methy-
lation (that is, H1 was methylated only if H3 was not
present).
These results suggested that, in comparison to H1, H3
is preferentially modified by both, SET7/9 and ARTD1.
In the short window when H1 methylation is inhibited
due to PARylation but H3 is not yet fully ADP-ribosylated,
SET7/9 dependent methylation of H3 is detectable. This
example thus illustrates how different affinities for
modifying enzymes can induce a switch of target pro-
teins. These results suggest that differential PARylation
of histone proteins by ARTD1 can indirectly influence
histone methylation and thus the histone code by deter-
mining which target proteins are modified. In addition
to crosstalk between PARylation and methylation,
SET7/9 function is thus also subject to crosstalk
between different substrates (for example, H3 and H1).
Figure 2 Histones H1 and H3 compete for SET7/9-dependent
methylation. (A) H3 and H1 compete for methylation by SET7/9. H1
was methylated in presence of the indicated molar ratios of H3. In
lanes 6 and 7, H3 was incubated with ARTD1 and NAD+ in the
presence or absence of 3-AB before addition of H1 and the
methylation reaction. (B) ARTD1 was auto-modified for the indicated
times and then inhibited by addition of PJ-34. H1 was added to the
reaction either before or after the PARylation. Methylation was
started after addition of PJ-34 by adding SET7/9 and 14C-SAM. (C) As
for (B), but a histone mix was used.
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SET7/9
In order to characterize the new SET7/9 methylation
target H1, different fragments of H1.4 were created and
their methylation was analyzed. Interestingly, full-length
histone H1.4 was not methylated in the presence of plas-
mid DNA and neither was an H1.4 mutant lacking the
C-terminus (ΔCT) (Figure 3A). These results suggested
that H1.4 is methylated at the C-terminal domain
(CTD), which has been reported to bind to DNA, and
that SET7/9 likely methylates soluble H1.4 that is
not part of the chromatin structure. In order to locate
the methylation site in histone H1.4, recombinant,
C-terminally truncated, HIS-tagged H1.4 fragments as
well as short fragments of the CTD were analyzed
(Figure 3B). Full length H1.4 (aa 1 to 219) was strongly
methylated, while partial truncation of the CTD (1 to
189 or 1 to 156) caused reduced SET7/9-dependent
methylation (Figure 3C). To further pinpoint the methy-
lation sites in the H1.4 CTD, three H1.4 fragments
covering the whole CTD were expressed as glutathione-
S-transferase (GST)-fusion proteins (aa 114 to 144, 145
to 189, 190 to 219, Figure 3B) and used in methylation
assays. All three fragments were methylated by SET7/9,
albeit to different degrees (Figure 3D). Fragment 190 to
219 showed the strongest methylation, while the frag-
ment from amino acids 114 to 144 was only weakly
methylated, suggesting that multiple SET7/9-dependent
methylation sites are present in the CTD of H1.4. These
results demonstrated that the linker histone H1.4 is
methylated by SET7/9 in vitro.Linker histone H1.4 is methylated at six lysine
residues of the C-terminal domain
In order to define all SET7/9-dependent methylation
sites in the CTD of the H1.4, the C-terminal fragments
(114 to 144, 145 to 189, 190 to 219) were further muta-
genized. Since the strongest methylation was seen for
fragments 145 to 189 and 190 to 219, these peptides
were subjected to a cluster mutation approach. Seven ly-
sine clusters that comprised all potential methylation
sites were defined and in each of these clusters all lysine
Figure 3 Linker histones are methylated by SET7/9. (A) HIS-tagged H1.4 FL and a deletion mutant without the CTD (ΔCTD) were in vitro
methylated by SET7/9 in the presence or absence of plasmid DNA. (B) Schematic depiction of H1.4 wild-type (WT) protein and constructs. NTD,
N-terminal domain; GD, globular domain; CTD, C-terminal domain; ΔCT, H1.4 construct completely lacking the C-terminus. (C) Recombinant HIS-
tagged H1.4 full-length (FL) and deletion mutants were methylated in vitro by SET7/9. (D) H1.4 C-terminal fragments were expressed as GST
fusion proteins and methylated in vitro by SET7/9. Methylation was analyzed by autoradiography.
Figure 4 Full-length H1.4 is methylated at six lysine residues by SET7/9. (A) Mutation of the four lysine residues K159, K171, K177 and K192
(K4R) in wild-type (WT) H1.4 reduces SET7/9-dependent methylation. The additional mutation of K121 and K129 (K6R) abolishes methylation of
full-length H1.4 by SET7/9. (B) H1.4 is efficiently PARylated after methylation by SET7/9. H1.4 was first incubated with S-adenosyl-L-(methyl-14C)
methionine (14C-SAM) and glutathione-S-transferase (GST) or SET7/9 and then incubated with ADP-ribosyltransferase-D1 (ARTD1) in the presence
or absence of cold nicotinamide adenine dinucleotide (NAD)+. (C) H1.4 K6R is still modified by ARTD1. H1.4 WT and K6R were incubated with
ARTD1 in the presence of 250 μM NAD+. PARylation was analyzed by Western blotting.
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Figure S2A). Mutation of cluster 4 and cluster 6 did not
interfere with the methylation of the H1.4 fragments, in-
dicating that the lysine residues located in these two
clusters are not methylated by SET7/9 (Additional file 2:
Figure S2B). The remaining cluster mutants 1, 2, 3, 5
and 7 were less methylated than the wild-type (WT)
proteins (Additional file 2: Figure S2B). Computational
analysis of these clusters as well as the fragment 114 to
144 identified six putative SET7/9 target sites matching
the (KR)(STA)K consensus motif for SET7/9-dependent
methylation [27]. These lysines at position 121, 129, 159,
171, 177 and 192 represent the last residues of the
six KAK motifs in the CTD of H1.4 (Additional file 2,
Figure S2A).
The corresponding lysine residues were then mutated
individually and in combination. Only the mutation of
all three lysines (K159, K171, K177) of the fragment 145
to 189 completely abolished the methylation of this pep-
tide (Additional file 2, Figure S2C). Similarly, the K192R
mutation abrogated the SET7/9-dependent methylation
of fragment 190 to 219 (Additional file 2, Figure S2D).
Interestingly, the combination of all four mutations
(K159R, K171R, K177R and K192R) did not completely
prevent the methylation of full-length H1.4 (Figure 4A).
The additional mutation of K121 and K129 of the
fragment 114 to 144 to arginines reduced the SET7/9-
dependent methylation of full-length H1.4 most signifi-
cantly, although a faint signal was sometimes observed
even for this peptide (Figure 4A).
In summary, the mapping of the methylation sites in
the H1.4 CTD thus identified the KAK motif and the six
lysines K121, K129, K159, K171, K177 and K192 as the
targets for SET7/9-dependent methylation of this linker
histone variant.
Histones H1.4 and H3 methylation does not affect
PARylation
The initial observation revealing H1 methylation by
SET7/9 indicated crosstalk between PARylation and
methylation as well as competition between H3 and
H1.4. In order to elucidate the nature of this crosstalk,
the influence of methylation on PARylation was studied
and additional competition experiments with H1.4 and
H3 were performed.
Prior methylation by SET7/9 did not prevent consecu-
tive H1.4 PARylation, as observed by the shift of methy-
lated H1 (Figure 4B). Similarly, the non-methylated H1.4
K6R mutant and WT H1.4 were modified by ARTD1
comparably (Figure 4C). These results clearly indicated
that PARylation and SET7/9-dependent methylation of
H3 and H1.4 do not crosstalk due to the same modifica-
tion sites, even though prior PARylation does prevent
methylation (Figures 2B, 2C). It is therefore likely thatPARylation inhibits SET7/9 interaction with PARylated
H3 or H1.4 and thereby prevents methylation.
Conclusions
This study describes the linker histone H1.4 as a new
target for the H3K4 mono-methyltransferase SET7/9.
Full-length histone H1.4 was methylated by SET7/9 at
the lysine residues K121, K129, K159, K171, K177 and
K192 of the KAK motifs of the CTD, which suggests a
strong preference of SET7/9 for this recognition se-
quence. However, some of the KAK motifs seemed pre-
ferentially methylated, which may indicate a sequential
modification or hint at differences in the accessibility of
the different methylation sites.
The addition of plasmid DNA abolished SET7/9-
dependent methylation of target proteins, indicating that
incorporation into the nucleosome structure and DNA
binding prevents methylation. This could be explained
by DNA-induced conformational changes of the H1
CTD and by charge neutralization through DNA, as
SET7/9 is known to prefer lysine residues in a positively
charged context. Likewise, methylation may directly in-
fluence the binding of H1 to DNA and its function in
chromatin compaction, especially as the six lysine resi-
dues targeted by SET7/9 all reside in the CTD of H1.4,
which is important for chromatin binding [28]. These
findings may indicate that SET7/9-dependent H1 methy-
lation appears when H1 is not chromatin bound and
possibly influences its turnover and exchange, which
extends the scope of the histone code to the extra-
chromatin realm.
Covalent histone modifications can alter chromatin
structure and thereby define transcriptionally active or
inactive chromatin states [29]. Compared with core his-
tones, little is known about the modifications and the
corresponding modifiers of the linker histones. One pos-
sible function of H1 methylation by SET7/9 might be
the stimulation or repression of other post-translational
modifications. Crosstalk between K26 dimethylation and
AuroraB-mediated phosphorylation of S27 has been
reported previously [25]. In addition, the H1.4 CTD is the
target of acetylation, ADP-ribosylation and phosphorylation
[30,31]. Interestingly, the four last KAK motifs, which
displayed the strongest methylation in vitro, are located in
close proximity to well known CDK phosphorylation sites
(Figure 5A), which suggests a potential for significant
crosstalk between acetylation, methylation and phosphoryl-
ation. Two of the sites in this region, S172 and S187, are
not exclusively phosphorylated during mitosis and their
phosphorylation in interphase correlated with transcription
and chromatin relaxation [32]. Crosstalk between dif-
ferent histone modifications of H1.4 thus can fulfill im-
portant cellular functions. However, in most cases the
modifying enzymes are currently not known and thus
Figure 5 Crosstalk between adenosine diphosphate-ribosyltransferase (ARTD)-1 and SET7/9-dependent modification of linker and
core histones. (A) Summary of known post-translational modification sites of H1.4. The grey box marks the central globular domain. The
six newly identified KAK motifs that are methylated by SET7/9 are highlighted in red. Blue: PARylation (PAR), red: phosphorylation (P),
green: methylation (me, number indicates methylation state). (B) Model of the sequential adenosine diphosphate (ADP)-ribosylation and
methylation reactions on histone H3 and H1 by ARTD1 and SET7/9.
Kassner et al. Epigenetics & Chromatin 2013, 6:1 Page 7 of 9
http://www.epigeneticsandchromatin.com/content/6/1/1the biological and cellular functions of these modifica-
tions have not been elucidated in detail yet.
ARTD1 and histone ADP-ribosylation were previously
suggested as components of the histone code [20,26]. The
results described here provide a further line of evidence
for this hypothesis. We show that ARTD1-dependent
PARylation of histones influences their subsequent methy-
lation by SET7/9. Compared to phosphorylation, which
strongly reduces methylation if in proximity of SET7/9
target lysine residues [12], PARylation is a much more
bulky modification with more negative charges and
therefore also inhibited histone methylation by SET7/9.
Based on the experiments shown here, SET7/9 methy-
lates both H1 and H3, but prefers H3 if both substrates
are present. Strikingly, PARylation did not merely in-
hibit SET7/9-dependent methylation of histones, but
shifted its target from H3 to H1 (Figure 5B). These
observations could be explained by sequential PARyla-
tion events, where ARTD1 modifies H3 before H1.
PARylation of H3 would then inhibit its subsequent
methylation by SET7/9 and its competition as a SET7/9
target with H1.
This ARTD1-dependent regulation of the substrate
specificity of a histone modifying enzyme may be an ex-
citing mechanism to explain how ARTD1 influenceschromatin-associated processes such as transcription. It
is also important to note that progressive PARylation of
histones also inhibited the methylation of H1, docu-
menting that different outcomes for SET7/9-dependent
histone methylation can occur depending on the extent
of ARTD1 activity.
The complexity of ARTD1-dependent histone modifi-
cations is increased by the facts that (1) ARTD1 can
modify all core histones and the linker histones [23], and
(2) the size and quality (for example, branching or
length) of the polymers may differ under varying condi-
tions and depending on the substrate histone. Therefore,
future studies should not merely focus on the influence
of ARTD1 and PARylation on other histone modifica-
tions but also on how ARTD1-dependent histone modi-
fication itself is regulated. In this regard, it will also be
interesting to study specific ADP-ribose modifications
and their effect on SET7/9 methylation. Although we
have identified ADP-ribose acceptor sites in histones
(for example, K37 of H3) it is not yet possible to chem-
ically synthesize peptides with specific ADP-ribose mod-
ifications required for these studies. Furthermore,
antibodies specific for a particular ADP-ribose modifica-
tion have not been developed. In the future, such tools
will allow study of the effect of SET7/9-dependent
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Methods
Plasmids and protein expression
pGEX-SET7/9 (52 to 366) and pET28b-H1.4 (fl) bacterial
expression vectors were kind gifts from D Reinberg and R
Schneider, respectively. H1.4 full-length and deletions
mutants were subcloned into pET-28a to add the N-
terminal HIS-tag. C-terminal H1.4 fragments were cloned
into pGEX6P1. All point mutations were inserted by site-
directed mutagenesis. Cluster mutants were created by
overlapping PCR with the corresponding primers.
The baculovirus expression vector BacPak8 (Clontech,
Mountain View, CA, USA) was used for the expression
of recombinant ARTD1 in Sf21 insect cells, as described
previously [33]. GST- and HIS-tagged histone proteins
were expressed in E.coli. All recombinant proteins were
purified by a one-step affinity chromatography using
ProBond resin (Invitrogen, Paisley, UK) for HIS-tagged
and glutathione sepharose (GE Healthcare, Uppsala,
Sweden) for GST-tagged proteins, according to the man-
ufacturer‘s recommendations. HIS-H1.4(fl) proteins were
purified as described elsewhere [34].
Reagents
Lyophilized histones or H1 mix from calf thymus were
purchased from Roche (Rotkreuz, Zug, Switzerland) and
resolubilized in water. The 3-AB (Sigma-Aldrich, St. Louis,
MO, USA) was freshly prepared in water.
In vitro methylation assays
If not stated otherwise, approximately 1 μg histone
proteins were incubated with 1 μg bacterially purified
GST-SET7/9 in the presence of 0.03 μCi 14C-SAM
(PerkinElmer, Boston, MA, USA) in methylation buffer
(50 mM Tris–HCl pH8.0, 50 mM NaCl, 10% glycerol, 1
mM PMSF, 1 mM DTT) for 10 to 60 minutes at 30°C in
a 25 μl reaction. For DNA inhibition assays, histones
were preincubated with or without 0.5 μg plasmid DNA
(pcDNA) and then methylated for 15 minutes. Reactions
were stopped by addition of 10× SDS-loading buffer,
boiled and separated by SDS-PAGE. Gels were stained
with CB, incubated in 1 M sodium salicylate for 20
minutes, dried, and exposed on x-ray film at −80°C.
Sequential ADP-ribosylation and methylation assays
Sequential modification assays were performed in PAR
buffer (50 mM Tris–HCl, 50 mM NaCl, 4 mM MgCl2,
250 μM DTT, 1 mg/ml pepstatin, 1 mg/ml bestatin, 1
mg/ml leupeptin).
We incubated 10 pmol ARTD1, with or without 2.5 μg
histone mix or 1 μg individual histones, in the presence
or absence of 5 pmol activating DNA and 160 μM NAD+(Sigma-Aldrich, St. Louis, MO, USA) for 15 minutes at
30°C; 8 mM 3-AB or 0.2 mM PJ-34 were added to inhibit
ARTD1 activity either before the ADP-ribosylation or
afterwards, where indicated. The methylation was then
started by addition of 1 μg SET7/9 and 0.03 μCi 14C-SAM
and allowed to proceed for 1 h at 30°C. Autoradiography
was performed as described above. The activating DNA
used in all assays was an annealed double-stranded
oligomer (5’-GGAATTCC-3’).
Additional files
Additional file 1: Figure S1. Time-dependent PARylation of adenosine
diphosphate-ribosyltransferase (ARTD)-1 and histones. ARTD1 and a
histone mix were modified for the indicated times. Proteins were
separated by SDS-PAGE, stained with Coomassie blue (CB, upper blot)
and adenosine diphosphate (ADP)-ribosylation was analyzed by
autoradiography (32P, lower blots showing a long and short exposure).
The mobility shift of poly-ADP-ribosylated ARTD1 is marked in the SDS-
PAGE gel.
Additional file 2: Figure S2. H1.4 C-terminal domain (CTD) is
methylated at KAK* motifs. (A) Amino acid sequences of C-terminal H1.4
fragments. Boxes represent the lysine clusters which were mutated to
arginines in (B). Grey boxes mark the clusters that markedly influence
methylation. KAK motifs are highlighted in dark grey and the methylated
lysines are bold. (B) Cluster mutant approach to identify methylation sites
in H1.4 CTD, which contains 43 lysine residues as potential target sites.
Clusters were mutated one by one in the corresponding C-terminal
fragment and methylation efficiency by SET7/9 was tested in vitro. (C)
Methylation of C-terminal fragments by SET7/9 was tested in vitro after
mutation of single lysine residues in KAK* motifs. (D) Methylation of H1.4
(145–189) double and triple mutants by SET7/9.
Abbreviations
ADP: Adenosine diphosphate; ART: Adenosine diphosphate ribosyltransferase;
CB: Coomassie blue; C-SAM: S-adenosyl-L-(methyl-14C) methionine; CTD: C-
terminal domain; ETD: Electron-transfer dissociation; GST: Glutathione-S-
transferase; LSD: Lysine-specific demethylase; NAD: Nicotinamide adenine
dinucleotide; PARP: Poly(ADP-ribose) polymerase; PCR: Polymerase chain
reaction; PTM: Post-translational modification; WT: Wild-type.
Competing interests
The authors declare that they have no conflicts of interest.
Authors’ contributions
IK and MOH designed the experiments; IK, MB, FR and MF performed
experiments; MOH designed and supervised the study. IK and MOH wrote
the manuscript. All the authors read and agreed with the manuscript.
Acknowledgements
We thank Danny Reinberg (Howard Hughes Medical Institute, NYU School of
Medicine, New York, USA) for providing SET7/9, Timothey J. Richmond
(Deportment of Biology, ETH Zurich, Switzerland) for providing purified
histone H3 and Robert Schneider (Max-Planck Institute of Immunobiology
and Epigenetics, Freiburg, Germany) for helpful advice. We are grateful to
Florian Freimoser and all the members of the Institute of Veterinary
Biochemistry and Molecular Biology (University of Zurich, Switzerland) for
helpful advice and discussions. This work was supported by Swiss National
Science Foundation Grants 31003A-122421 and 310030B-138667 (to MOH)
and the Kanton of Zurich (to MOH).
Author details
1Institute of Veterinary Biochemistry and Molecular Biology, University of
Zurich, Winterthurerstrasse 190, Zurich 8057, Switzerland. 2Life Science Zurich
Graduate School, Molecular Life Science Program, University of Zurich,
Zurich, Switzerland.
Kassner et al. Epigenetics & Chromatin 2013, 6:1 Page 9 of 9
http://www.epigeneticsandchromatin.com/content/6/1/1Received: 12 December 2012 Accepted: 14 December 2012
Published: 5 January 2013References
1. Campos E, Reinberg D: Histones: annotating chromatin. Annu Rev Genet
2009, 43:559–599.
2. Kornberg RD, Lorch Y: Twenty-five years of the nucleosome, fundamental
particle of the eukaryote chromosome. Cell 1999, 98:285–294.
3. Annunziato AT: DNA packaging: nucleosomes and chromatin. Nature
Education 2008, 1(1). http://www.nature.com/scitable/topicpage/dna-
packaging-nucleosomes-and-chromatin-310.
4. Happel N, Doenecke D: Histone H1 and its isoforms: contribution to
chromatin structure and function. Gene 2009, 431:1–12.
5. Shen X, Gorovsky MA: Linker histone H1 regulates specific gene
expression but not global transcription in vivo. Cell 1996, 86:475–483.
6. Ramakrishnan V, Finch JT, Graziano V, Lee PL, Sweet RM: Crystal structure
of globular domain of histone H5 and its implications for nucleosome
binding. Nature 1993, 362:219–223.
7. Hendzel MJ, Lever MA, Crawford E, Th'ng JP: The C-terminal domain is the
primary determinant of histone H1 binding to chromatin in vivo.
J Biol Chem 2004, 279:20028–20034.
8. Izzo A, Kamieniarz K, Schneider R: The histone H1 family: specific
members, specific functions? Biol Chem 2008, 389:333–343.
9. Raghuram N, Carrero G, Th'ng J, Hendzel MJ: Molecular dynamics of
histone H1. Biochem Cell Biol 2009, 87:189–206.
10. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang
Y: Purification and functional characterization of a histone H3-lysine
4-specific methyltransferase. Mol Cell 2001, 8:1207–1217.
11. Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P,
Reinberg D: Set9, a novel histone H3 methyltransferase that facilitates
transcription by precluding histone tail modifications required for
heterochromatin formation. Genes Dev 2002, 16:479–489.
12. Dhayalan A, Kudithipudi S, Rathert P, Jeltsch A: Specificity analysis-based
identification of new methylation targets of the SET7/9 protein lysine
methyltransferase. Chem Biol 2011, 18:111–120.
13. Klose RJ, Zhang Y: Regulation of histone methylation by
demethylimination and demethylation. Nat Rev Mol Cell Biol 2007,
8:307–318.
14. Mosammaparast N, Shi Y: Reversal of histone methylation: biochemical
and molecular mechanisms of histone demethylases. Annu Rev Biochem
2010, 79:155–179.
15. Hottiger MO, Hassa PO, Lüscher B, Schüler H, Koch-Nolte F: Toward a
unified nomenclature for mammalian ADP-ribosyltransferases.
Trends Biochem Sci 2010, 35:208–219.
16. Yamanaka H, Penning CA, Willis EH, Wasson DB, Carson DA:
Characterization of human poly(ADP-ribose) polymerase with
autoantibodies. J Biol Chem 1988, 263:3879–3883.
17. D'Amours D, Desnoyers S, D'Silva I, Poirier GG: Poly(ADP-ribosyl)ation
reactions in the regulation of nuclear functions. Biochem J 1999,
342(Pt 2):249–268.
18. Gibson BA, Kraus WL: New insights into the molecular and cellular
functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 2012,
13:411–424.
19. Altmeyer M, Hottiger MO: Poly(ADP-ribose) polymerase 1 at the crossroad
of metabolic stress and inflammation in aging. Aging 2009, 1:458–469.
20. Hottiger MO: ADP-ribosylation of histones by ARTD1: an additional
module of the histone code? FEBS Lett 2011, 585:1595–1599.
21. Huletsky A, de Murcia G, Muller S, Hengartner M, Ménard L, Lamarre D,
Poirier G: The effect of poly(ADP-ribosyl)ation on native and H1-depleted
chromatin. A role of poly(ADP-ribosyl)ation on core nucleosome
structure. J Biol Chem 1989, 264:8878–8886.
22. Adamietz P, Hilz H: Poly(adenosine diphosphate ribose) is covalently
linked to nuclear proteins by two types of bonds. Hoppe Seylers Z Physiol
Chem 1976, 357:527–534.
23. Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, Rutishauser
D, Huang D, Caflisch A, Hottiger MO: PARP1 ADP-ribosylates lysine
residues of the core histone tails. Nucleic Acids Res 2010, 38:6350–6362.
24. Kouzarides T: Chromatin modifications and their function. Cell 2007,
128:693–705.25. Hergeth SP, Dundr M, Tropberger P, Zee BM, Garcia BA, Daujat S,
Schneider R: Isoform-specific phosphorylation of human linker histone
H1.4 in mitosis by the kinase Aurora B. J Cell Sci 2011, 124:1623–1628.
26. Messner S, Hottiger MO: Histone ADP-ribosylation in DNA repair,
replication and transcription. Trends Cell Biol 2011, 21:534–542.
27. Couture JF, Collazo E, Hauk G, Trievel RC: Structural basis for the
methylation site specificity of SET7/9. Nat Struct Mol Biol 2006,
13:140–146.
28. Caterino TL, Hayes JJ: Structure of the H1 C-terminal domain and function
in chromatin condensation. Biochem Cell Biol 2011, 89:35–44.
29. Jenuwein T, Allis CD: Translating the histone code. Science 2001,
293:1074–1080.
30. Ogata N, Ueda K, Kagamiyama H, Hayaishi O: ADP-ribosylation of histone
H1. Identification of glutamic acid residues 2, 14, and the COOH-
terminal lysine residue as modification sites. J Biol Chem 1980,
255:7616–7620.
31. Wisniewski JR, Zougman A, Kruger S, Mann M: Mass spectrometric
mapping of linker histone H1 variants reveals multiple acetylations,
methylations, and phosphorylation as well as differences between cell
culture and tissue. Mol Cell Proteomics 2007, 6:72–87.
32. Zheng Y, John S, Pesavento JJ, Schultz-Norton JR, Schiltz RL, Baek S,
Nardulli AM, Hager GL, Kelleher NL, Mizzen CA: Histone H1
phosphorylation is associated with transcription by RNA polymerases
I and II. J Cell Biol 2010, 189:407–415.
33. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO: Transcriptional
coactivation of nuclear factor-κB-dependent gene expression by p300 is
regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 2003,
278:45145–45153.
34. Weiss T, Hergeth S, Zeissler U, Izzo A, Tropberger P, Zee BM, Dundr M,
Garcia BA, Daujat S, Schneider R: Histone H1 variant-specific lysine
methylation by G9a/KMT1C and Glp1/KMT1D.
Epigenetics Chromatin 2010, 3:7.
doi:10.1186/1756-8935-6-1
Cite this article as: Kassner et al.: Crosstalk between SET7/9-dependent
methylation and ARTD1-mediated ADP-ribosylation of histone H1.4.
Epigenetics & Chromatin 2013 6:1.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
